Top Back to top

Hybrid 49th Annual Meeting of the EBMT


The official website and registration for the Hybrid 49th Annual Meeting of EBMT will open in September 2022.


Dear friends and colleagues,

​I would like to formally invite and welcome you to the 49th Annual Meeting of the EBMT being held in Paris, France from 23-26 April 2023.

Over the last few years, the stem cell transplant and cellular therapy fields have made significant progress. We have seen the introduction of fascinating innovations and the whole treatment paradigm is changing at an accelerated pace. The best way to stay up to date on revolutionary science and research plus the latest advances in the field and to improve patient care is to attend the 49th Annual Meeting of the EBMT in 2023.

This is your opportunity not only to see cutting-edge scientific content related to transplantation and cellular therapy, but also to network with thousands of top healthcare professionals from all over the world.

I encourage you to fully explore the scientific programme and attend other superb parts of the meeting like the 17th Patient, Family and Donor Day and the Nurses Group, Data Management Group and Quality Management Group programmes. 

The Annual Meeting of the EBMT is an event for all. There are even special tracks dedicated to Cell Therapy, Paediatrics, Pharmacists, Psychologists, Transplant Coordinators, Lab Technicians and Trainees. 

I am very much looking forward to seeing friends, colleagues and new faces in attendance and enjoying the most spectacular city of Paris in April of next year – even more so after three consecutive years of virtual meetings. Save the date and I hope to see you there!


Prof. Mohamad Mohty
Congress President


In the First Announcement PDF you can view the list of abstract topics being accepted for Physicians and Nurses at the Hybrid 49th Annual Meeting of the EBMT.

There are various opportunities to support Europe’s largest annual conference in bone marrow transplantation and cellular therapies. For more information, please send an email to to indicate your interest.